Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label
Go back to Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 22.50 -0.49 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.99 | 52 Week High | $63.73 | |||
| Open | $22.58 | 52 Week Low | $8.00 | |||
| Day High | $22.65 | P/E | N/A | |||
| Day Low | $21.98 | EPS | $-5.69 | |||
| Volume | 2,955,534 | |||||
